Recombinant Human APOA2 Protein (HEK293)，His

Apolipoprotein A2 (APOA2) is a significant protein component of high-density lipoproteins (HDL) in the human body, playing a crucial role in lipid metabolism, cholesterol transport, and cardiovascular health. Its relevance has been underscored by studies linking variations in the APOA2 gene to obesity, metabolic disorders, and the modulation of HDL cholesterol levels. Despite its importance, the detailed mechanism of action and the pathway through which APOA2 influences lipid metabolism remain poorly understood. To elucidate these mechanisms, research has focused on the production of recombinant APOA2 proteins, enabling detailed investigation of their structural and functional properties. The utilization of recombinant DNA technology permits the generation of large quantities of pure APOA2, facilitating biochemical studies and functional assays. These studies aim to explore how APOA2 interacts with lipids and other proteins in the extracellular environment, as well as its role in influencing the composition and functionality of HDL particles. Additionally, understanding the structural characteristics of recombinant APOA2 can provide insights into its stability, ligand binding, and potential therapeutic applications for conditions related to dyslipidemia and atherosclerosis. Overall, the research on recombinant APOA2 not only enhances our comprehension of lipid metabolism but also opens new avenues for the development of novel therapeutic strategies targeting cardiovascular diseases.